About Greg Brozeit

Articles by Greg Brozeit

MCRT Webcast: Myeloma Genetics with Three Experts
Sep 22, 2020
MCRT Webcast: Three Newly Approved Myeloma Treatments
Aug 21, 2020
MCRT Webcast: Experts Discuss Newly Diagnosed Multiple Myeloma Issues
Jun 05, 2020
No descuide el tratamiento del mieloma durante la pandemia
May 02, 2020
FDA Asked to Approve Use of Multiple Myeloma BMS/bluebird bio CAR T-cell Therapy
Apr 02, 2020
There's a New Kid In Town: Dr. William Matsui Develops New Multiple Myeloma Research Program in Austin, Texas
Aug 06, 2019
ASH 2018: Adding Daratumumab to Velcade/Revlimid/Dex Effective for Newly Diagnosed Multiple Myeloma
Dec 08, 2018
ASH 2018: Ixazomib and Elotuzumab Combos are Promising for High-Risk Smoldering Patients
Dec 08, 2018
La lección de Lennart Thy para el mundo
Mar 29, 2018
Will Blood Cancer Gene Therapy Be Affordable?
Sep 14, 2017
Policy and Politics: What Cancer Advocates Must Understand
May 10, 2017
High-Risk Multiple Myeloma Patients Benefit from Aggressive Treatment
Apr 27, 2017
Don’t Obsess About Cancer Causes
Mar 30, 2017
Columbus, Ohio Event Leads Way for African American Myeloma Patients
Mar 13, 2017
Required Reading: The Gene
Jul 25, 2016
National Comprehensive Cancer Network (NCCN) Announces Unprecedented Myeloma Guidelines
Apr 06, 2016
Lucky Man: The Inspiring Story of 24-YEAR Myeloma Survivor Jim Bond
Mar 15, 2016
Opposition Research: Uncomfortable Truths Cancer Advocates Must Confront
Jan 30, 2016
Myeloma? Prevention? Really?
Jan 30, 2016
Magic Bullets to Moon Shots
Jan 20, 2016
Patients as Agents of Change
Apr 08, 2015